[1]
Rupp SM,Apfelbaum JL,Blitt C,Caplan RA,Connis RT,Domino KB,Fleisher LA,Grant S,Mark JB,Morray JP,Nickinovich DG,Tung A, Practice guidelines for central venous access: a report by the American Society of Anesthesiologists Task Force on Central Venous Access. Anesthesiology. 2012 Mar; [PubMed PMID: 22307320]
[2]
Freel AC,Shiloach M,Weigelt JA,Beilman GJ,Mayberry JC,Nirula R,Stafford RE,Tominaga GT,Ko CY, American College of Surgeons Guidelines Program: a process for using existing guidelines to generate best practice recommendations for central venous access. Journal of the American College of Surgeons. 2008 Nov; [PubMed PMID: 18954779]
[3]
O'Grady NP,Alexander M,Dellinger EP,Gerberding JL,Heard SO,Maki DG,Masur H,McCormick RD,Mermel LA,Pearson ML,Raad II,Randolph A,Weinstein RA, Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports. 2002 Aug 9; [PubMed PMID: 12233868]
[5]
van de Weerdt EK,Biemond BJ,Baake B,Vermin B,Binnekade JM,van Lienden KP,Vlaar APJ, Central venous catheter placement in coagulopathic patients: risk factors and incidence of bleeding complications. Transfusion. 2017 Oct; [PubMed PMID: 28856685]
[6]
Chaiyakunapruk N,Veenstra DL,Lipsky BA,Saint S, Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Annals of internal medicine. 2002 Jun 4; [PubMed PMID: 12044127]
[7]
Mimoz O,Lucet JC,Kerforne T,Pascal J,Souweine B,Goudet V,Mercat A,Bouadma L,Lasocki S,Alfandari S,Friggeri A,Wallet F,Allou N,Ruckly S,Balayn D,Lepape A,Timsit JF, Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial. Lancet (London, England). 2015 Nov 21; [PubMed PMID: 26388532]
[8]
Geffers C,Meyer E, No reason to conclude that maximal sterile barrier precautions do not reduce catheter-related blood stream infections. Annals of surgery. 2011 Jan; [PubMed PMID: 21135688]
[9]
Han Z,Liang SY,Marschall J, Current strategies for the prevention and management of central line-associated bloodstream infections. Infection and drug resistance. 2010; [PubMed PMID: 21694903]
[10]
Gilbert M,Gallagher SC,Eads M,Elmore MF, Microbial growth patterns in a total parenteral nutrition formulation containing lipid emulsion. JPEN. Journal of parenteral and enteral nutrition. 1986 Sep-Oct; [PubMed PMID: 3093706]
[11]
Raad I,Hanna HA,Awad A,Alrahwan A,Bivins C,Khan A,Richardson D,Umphrey JL,Whimbey E,Mansour G, Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours? Infection control and hospital epidemiology. 2001 Mar; [PubMed PMID: 11310690]